Heart failure

Expect more heart and lung failure after COVID

Dr. Philip Adamson is medical director of Abbott’s heart failure business [Photo courtesy of Abbott]

Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body.

What remains to be seen is how the virus – and perhaps more importantly, our immune system’s response to it – will affect people’s health long after infection, even in mild cases. . This once-in-a-century pandemic that has already killed millions around the world could leave hundreds of millions more with chronic illnesses of varying severity.

“Not only is viral infection bad for some people, but the body’s subsequent reaction to viral illness in many people is remarkable. Personally, I’ve never seen anything like it,” said Dr. Philip Adamson, medical director of Abbott’s heart failure business. “I’ve been through and followed the AIDS epidemic and learned a lot about viral pathophysiology, but what it does in some people is amazing, and amazing that it only does in some people. … Every organ is sensitive.

In an interview with Medical design and outsourcingAdamson discussed the potential long-term cardiovascular impacts of COVID, which medical devices and components are likely to be in greater demand in coming decades, and how industry should think about design and diversity in our new reality.

Get the full story about our sisterter site, Medical Design & Outsourcing.